首页 > 市场调查报告书 > 製药

癌症以基因为基之药物开发

市场调查报告书

商品编码

1259887

癌症治疗的基因学市场:占有率，规模，趋势，产业分析报告，各产品，各技术，各用途，各最终用途，各地区，各市场区隔预测，2023年～2032年

Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, Instrument and Services); By Technology; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032

出版日期: 2023年03月01日 | 出版商:

Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球癌症治疗的基因学的市场规模到2032年前将达到728亿7,000万美元。

本报告提供全球癌症治疗的基因学市场相关调查，提供各产品，各技术，各用途，各最终用途，各地区趋势，及加入此市场的主要企业简介等资讯。

主要调查结果
简介
- 全球癌症治疗的基因学市场评估，各地区，2019年～2032年(10亿美元)
癌症治疗的基因学市场-北美
癌症治疗的基因学市场-欧洲
癌症治疗的基因学市场-亚太地区
癌症治疗的基因学市场-中东·非洲
癌症治疗的基因学市场-南美

第10章竞争情形

第11章企业简介

Agilent Technologies
Roche Diagnostics
Beckman Coulter
Illumina, Inc
Affymetrix
Cancer Genetic Inc
Bio-Rad Labs
Pacific Bio-science
Sigma Aldrich Corporation
GE Healthcare
Quest Diagnostics
Abbott Laboratories
PerkinElmer
Luminex

简介目录图表

Product Code: PM1607

The global genomics in cancer care market size is expected to reach USD 72.87 billion by 2032, according to a new study by Polaris Market Research. The report "Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, Instrument and Services); By Technology; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is primarily driven by the increasing prevalence of cancer patients globally, and rising demand for diagnostics coupled with the availability of cost-effective and technologically advanced technology. Additionally, awareness and growing preference for personalized medicines is also influencing the market growth. Moreover, continuous investment in research and developments by the biotechnology & pharmaceutical companies would also fuel the market growth.

The COVID-19 epidemic has drastically altered the healthcare business as a whole, and its effects may be seen in many areas of the industry. To create an effective vaccine or cutting-edge therapy for COVID-19, both the government and commercial pharmaceutical and biotechnology businesses have intensified their research operations and raised their funding.

Monitoring the coronavirus genome sequence can assist determine how an infection spreads and what effects it has on the human genome. With this knowledge, an infectious treatment strategy may subsequently be created. Researchers are tracing the genesis of COVID-19 infection in their nations and the start of community transmission using the viral genome data.

Genome sequencing has enormous potential, which has led to an increase in start-ups in recent years. Several businesses have begun offering sequencing services for a range of purposes, including nutrition, ancestry, genetic illnesses, and others, as a result of the enormous potential presented by genome sequencing. It is anticipated that start-up companies would receive more capital, which will help the industry expand.

For instance, consumer genomics business Ancestry is expected to provide a new product with next-generation sequencing in August 2020. Ancestry Health, a new solution driven by Next Generation Sequencing (NGS) that promises to give clients insights into their health and risk factors, may check for genes linked to blood diseases, colon cancer, breast cancer, and heart disease.

Genomics in Cancer Care Market Report Highlights:

Instruments hold the major share in the market owing to the rapid technological advancements and continuous efforts by the manufacturers for providing digitalization in the instruments for easy use.

Genome sequencing holds the major market share and would continue to experience growth during the forecast period. The growth in this segment is majorly driven by the effective and precise diagnosis results and rising awareness for its use in cancer diagnosis

Diagnostics application holds the largest market share which is majorly attributed to the growing number of cancer patients worldwide.

North America holds a dominating position in the global market followed by Europe and Asia Pacific. The market growth in North America is driven by the presence of refined research & development infrastructure for the researchers, a large pool of patients suffering from cancer, and high healthcare expenditure by individuals.

The global key market players include Agilent Technologies, Roche Diagnostics, Beckman Coulter, Illumina, Inc., Affymetrix, Cancer Genetic Inc., Bio-Rad Labs, Pacific Bio-science, Sigma Aldrich Corporation, GE Healthcare, Quest Diagnostics, Abbott Laboratories, PerkinElmer, and Luminex.

Polaris Market Research has segmented the Genomics in Cancer Care market report based on product, technology, application, end-use, and region:

Genomics in Cancer Care, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Consumable

Instrument

services

Genomics in Cancer Care, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

Gene Sequencing

PCR

Microarray Nucleic Acid Extraction and Purification

Genomics in Cancer Care, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Diagnostics

Personalized Medicines

Drug Delivery

Research

Genomics in Cancer Care, End-use (Revenue - USD Billion, 2019 - 2032)

Hospitals

Research Institutes

Academic Research

Genomics in Cancer Care, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Genomics in Cancer Care Market Insights

4.1. Genomics in Cancer Care - Industry Snapshot
4.2. Genomics in Cancer Care Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Initiatives taken by Companies in Product Development
  - 4.2.1.2. Growing Burden of Cancer
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Instruments and Procedures
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Genomics in Cancer Care Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Genomics in Cancer Care Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
5.3. Consumable
- 5.3.1. Global Genomics in Cancer Care Market, by Consumable, by Region, 2019-2032 (USD Billion)
5.4. Instrument
- 5.4.1. Global Genomics in Cancer Care Market, by Instrument, by Region, 2019-2032 (USD Billion)
5.5. Services
- 5.5.1. Global Genomics in Cancer Care Market, by Services, by Region, 2019-2032 (USD Billion)

6. Global Genomics in Cancer Care Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
6.3. Genome sequencing
- 6.3.1. Global Genomics in Cancer Care Market, by Genome sequencing, by Region, 2019-2032 (USD Billion)
6.4. PCR
- 6.4.1. Global Genomics in Cancer Care Market, by PCR, by Region, 2019-2032 (USD Billion)
6.5. Microarray Nucleic Acid Extraction and Purification
- 6.5.1. Global Genomics in Cancer Care Market, by Microarray Nucleic Acid Extraction and Purification, by Region, 2019-2032 (USD Billion)

7. Global Genomics in Cancer Care Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
7.3. Diagnostics
- 7.3.1. Global Genomics in Cancer Care Market, by Diagnostics, by Region, 2019-2032 (USD Billion)
7.4. Personalized Medicines
- 7.4.1. Global Genomics in Cancer Care Market, by Personalized Medicines, by Region, 2019-2032 (USD Billion)
7.5. Drug Delivery
- 7.5.1. Global Genomics in Cancer Care Market, by Drug Delivery, by Region, 2019-2032 (USD Billion)
7.6. Research
- 7.6.1. Global Genomics in Cancer Care Market, by Research, by Region, 2019-2032 (USD Billion)

8. Global Genomics in Cancer Care Market, by End-use

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
8.3. Hospitals
- 8.3.1. Global Genomics in Cancer Care Market, by Hospitals, by Region, 2019-2032 (USD Billion)
8.4. Research Institutes
- 8.4.1. Global Genomics in Cancer Care Market, by Research Institutes, by Region, 2019-2032 (USD Billion)
8.5. Academic Research
- 8.5.1. Global Genomics in Cancer Care Market, by Academic Research, by Region, 2019-2032 (USD Billion)

9. Global Genomics in Cancer Care Market, by Geography

9.1. Key findings
9.2. Introduction
- 9.2.1. Genomics in Cancer Care Market Assessment, By Geography, 2019-2032 (USD Billion)
9.3. Genomics in Cancer Care Market - North America
- 9.3.1. North America: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
- 9.3.2. North America: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
- 9.3.3. North America: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
- 9.3.4. North America: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.3.5. Genomics in Cancer Care Market - U.S.
  - 9.3.5.1. U.S.: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.3.5.2. U.S.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.3.5.3. U.S.: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.3.5.4. U.S.: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.3.6. Genomics in Cancer Care Market - Canada
  - 9.3.6.1. Canada: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.3.6.2. Canada: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.3.6.3. Canada: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.3.6.4. Canada: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
9.4. Genomics in Cancer Care Market - Europe
- 9.4.1. Europe: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
- 9.4.2. Europe: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
- 9.4.3. Europe: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
- 9.4.4. Europe: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.4.5. Genomics in Cancer Care Market - UK
  - 9.4.5.1. UK: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.4.5.2. UK: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.4.5.3. UK: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.4.5.4. UK: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.4.6. Genomics in Cancer Care Market - France
  - 9.4.6.1. France: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.4.6.2. France: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.4.6.3. France: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.4.6.4. France: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.4.7. Genomics in Cancer Care Market - Germany
  - 9.4.7.1. Germany: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.4.7.2. Germany: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.4.7.3. Germany: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.4.7.4. Germany: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.4.8. Genomics in Cancer Care Market - Italy
  - 9.4.8.1. Italy: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.4.8.2. Italy: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.4.8.3. Italy: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.4.8.4. Italy: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.4.9. Genomics in Cancer Care Market - Spain
  - 9.4.9.1. Spain: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.4.9.2. Spain: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.4.9.3. Spain: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.4.9.4. Spain: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.4.10. Genomics in Cancer Care Market - Netherlands
  - 9.4.10.1. Netherlands: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.4.10.2. Netherlands: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.4.10.3. Netherlands: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.4.10.4. Netherlands: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.4.11. Genomics in Cancer Care Market - Russia
  - 9.4.11.1. Russia: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.4.11.2. Russia.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.4.11.3. Russia: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.4.11.4. Russia: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
9.5. Genomics in Cancer Care Market - Asia Pacific
- 9.5.1. Asia Pacific: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.5.5. Genomics in Cancer Care Market - China
  - 9.5.5.1. China: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.5.5.2. China.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.5.5.3. China: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.5.5.4. China: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.5.6. Genomics in Cancer Care Market - India
  - 9.5.6.1. India: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.5.6.2. India.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.5.6.3. India: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.5.6.4. India: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.5.7. Genomics in Cancer Care Market - Japan
  - 9.5.7.1. Japan: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.5.7.2. Japan.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.5.7.3. Japan: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.5.7.4. Japan: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.5.8. Genomics in Cancer Care Market - Malaysia
  - 9.5.8.1. Malaysia: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.5.8.2. Malaysia.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.5.8.3. Malaysia: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.5.8.4. Malaysia: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.5.9. Genomics in Cancer Care Market - Indonesia
  - 9.5.9.1. Indonesia: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.5.9.2. Indonesia.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.5.9.3. Indonesia: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.5.9.4. Indonesia: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.5.10. Genomics in Cancer Care Market - South Korea
  - 9.5.10.1. South Korea: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.5.10.2. South Korea.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.5.10.3. South Korea: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.5.10.4. South Korea: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
9.6. Genomics in Cancer Care Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.6.5. Genomics in Cancer Care Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.6.6. Genomics in Cancer Care Market - South Africa
  - 9.6.6.1. South Africa: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.6.6.2. South Africa: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.6.6.3. South Africa: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.6.6.4. South Africa: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.6.7. Genomics in Cancer Care Market - Israel
  - 9.6.7.1. Israel: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.6.7.2. Israel: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.6.7.3. Israel: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.6.7.4. Israel: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.6.8. Genomics in Cancer Care Market - UAE
  - 9.6.8.1. UAE: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.6.8.2. UAE: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.6.8.3. UAE: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.6.8.4. UAE: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
9.7. Genomics in Cancer Care Market - Latin America
- 9.7.1. Latin America: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.7.5. Genomics in Cancer Care Market - Mexico
  - 9.7.5.1. Mexico: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.7.5.2. Mexico: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.7.5.3. Mexico: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.7.5.4. Mexico: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.7.6. Genomics in Cancer Care Market - Brazil
  - 9.7.6.1. Brazil: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.7.6.2. Brazil: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.7.6.3. Brazil: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.7.6.4. Brazil: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
- 9.7.7. Genomics in Cancer Care Market - Argentina
  - 9.7.7.1. Argentina: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
  - 9.7.7.2. Argentina: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
  - 9.7.7.3. Argentina: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
  - 9.7.7.4. Argentina: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Agilent Technologies
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Roche Diagnostics
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Beckman Coulter
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Illumina, Inc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Affymetrix
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Cancer Genetic Inc
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Bio-Rad Labs
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Pacific Bio-science
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Sigma Aldrich Corporation
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. GE Healthcare
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Quest Diagnostics
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Abbott Laboratories
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. PerkinElmer
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Luminex
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development

简介目录图表

List of Tables

Table 1 Global Genomics in Cancer Care Market, by Product, by Region, 2019-2032 (USD Billion)
Table 2 Global Genomics in Cancer Care Market, by Technology, by Region, 2019-2032 (USD Billion)
Table 3 Global Genomics in Cancer Care Market, by Application, by Region, 2019-2032 (USD Billion)
Table 4 Global Genomics in Cancer Care Market, by End-use, by Region, 2019-2032 (USD Billion)
Table 5 Genomics in Cancer Care Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 6 North America: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 7 North America: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 8 North America: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 9 North America: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 10 U.S.: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 11 U.S.: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 12 U.S.: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 13 U.S.: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 14 Canada: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 15 Canada: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 16 Canada: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 17 Canada: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 18 Europe: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 19 Europe: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 20 Europe: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 21 Europe: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 22 Germany: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 23 Germany: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 24 Germany: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 25 Germany: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 26 France: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 27 France: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 28 France: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 29 France: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 30 UK: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 31 UK: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 32 UK: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 33 UK: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 34 Italy: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 35 Italy: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 36 Italy: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 37 Italy: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 38 Netherlands: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 39 Netherlands: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 40 Netherlands: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 41 Netherlands: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 42 Spain: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 43 Spain: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 44 Spain: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 45 Spain: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 46 Russia: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 47 Russia: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 48 Russia: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 49 Russia: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 50 Asia Pacific: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 51 Asia Pacific: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 52 Asia Pacific: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 53 Asia Pacific: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 54 China: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 55 China: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 56 China: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 57 China: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 58 Japan: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 59 Japan: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 60 Japan: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 61 Japan: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 62 India: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 63 India: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 64 India: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 65 India: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 66 Indonesia: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 67 Indonesia: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 68 Indonesia: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 69 Indonesia: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 70 Malaysia: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 71 Malaysia: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 72 Malaysia: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 73 Malaysia: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 74 South Korea: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 75 South Korea: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 76 South Korea: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 77 South Korea: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 78 Latin America: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 79 Latin America: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 80 Latin America: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 81 Latin America: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 82 Brazil: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 83 Brazil: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 84 Brazil: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 85 Brazil: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 86 Mexico: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 87 Mexico: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 88 Mexico: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 89 Mexico: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 90 Argentina: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 91 Argentina: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 92 Argentina: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 93 Argentina: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 94 Middle East & Africa: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 95 Middle East & Africa: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 96 Middle East & Africa: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 97 Middle East & Africa: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 98 UAE: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 99 UAE: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 100 UAE: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 101 UAE: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 102 Saudi Arabia: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 103 Saudi Arabia: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 104 Saudi Arabia: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 105 Saudi Arabia: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 106 South Africa: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 107 South Africa: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 108 South Africa: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 109 South Africa: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)
Table 110 Israel: Genomics in Cancer Care Market, by Product, 2019-2032 (USD Billion)
Table 111 Israel: Genomics in Cancer Care Market, by Technology, 2019-2032 (USD Billion)
Table 112 Israel: Genomics in Cancer Care Market, by Application, 2019-2032 (USD Billion)
Table 113 Israel: Genomics in Cancer Care Market, by End-use, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Genomics in Cancer Care Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up End-use
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Product
Figure 7. Global Genomics in Cancer Care Market, by Product, 2021 & 2030 (USD Billion)
Figure 8. Market by End-use
Figure 9. Global Genomics in Cancer Care Market, by End-use, 2021 & 2030 (USD Billion)
Figure 10. Market by Technology
Figure 11. Global Genomics in Cancer Care Market, by Technology, 2021 & 2030 (USD Billion)
Figure 12. Market by Application
Figure 13. Global Genomics in Cancer Care Market, by Application, 2021 & 2030 (USD Billion)

02-2729-4219

+886-2-2729-4219

License/价格

癌症治疗的基因学市场:占有率，规模，趋势，产业分析报告，各产品，各技术，各用途，各最终用途，各地区，各市场区隔预测，2023年～2032年

Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, Instrument and Services); By Technology; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032

目录

第1章简介

第2章摘要整理

第3章调查手法

第4章全球癌症治疗的基因学市场洞察

第5章全球癌症治疗的基因学市场，各产品

第6章全球癌症治疗的基因学市场，各技术

第7章全球癌症治疗的基因学市场，各用途

第8章全球癌症治疗的基因学市场，各最终用途

第9章全球癌症治疗的基因学市场，各地区